Rhythm Pharmaceuticals Inc (RYTM)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
63.76 +0.79 (+1.25%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 65.00 +1.24 (+1.94%) 19:55 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -260,602 | -184,678 | -181,119 | -69,612 | -133,996 |
| Depreciation Amortization | 1,563 | 1,758 | 1,672 | 1,158 | 690 |
| Accounts receivable | -3,645 | -8,643 | -5,199 | -1,250 | N/A |
| Accounts payable and accrued liabilities | 21,918 | 14,773 | 1,543 | 18,312 | -6,446 |
| Other Working Capital | 10,575 | 4,807 | -17,410 | 1,897 | -5,895 |
| Other Operating Activity | 116,312 | 35,826 | 27,085 | -96,508 | 23,667 |
| Operating Cash Flow | $-113,879 | $-136,157 | $-173,428 | $-146,003 | $-121,980 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,673 | 49 | 32,310 | -163,725 | 158,745 |
| PPE Investments | -40,500 | -5,714 | -281 | -434 | -214 |
| Purchase Sale Intangibles | 0 | 0 | -4,000 | 2,000 | 0 |
| Other Investing Activity | 0 | 0 | -4,000 | 102,000 | 0 |
| Investing Cash Flow | $-48,173 | $-5,665 | $28,029 | $-62,159 | $158,531 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 24,370 | 72,338 | 0 | 0 |
| Debt Repayment | -12,900 | -7,398 | 0 | 0 | N/A |
| Common Stock Issued | 56,392 | 57,396 | 141,490 | 166,481 | 2,009 |
| Other Financing Activity | 147,750 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $191,242 | $74,368 | $213,828 | $166,481 | $2,009 |
| Exchange Rate Effect | 2 | -142 | 0 | 0 | N/A |
| Beginning Cash Position | 60,409 | 128,005 | 59,576 | 101,257 | 62,697 |
| End Cash Position | 89,601 | 60,409 | 128,005 | 59,576 | 101,257 |
| Net Cash Flow | $29,192 | $-67,596 | $68,429 | $-41,681 | $38,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113,879 | -136,157 | -173,428 | -146,003 | -121,980 |
| Capital Expenditure | -40,500 | -5,714 | -281 | -434 | -214 |
| Free Cash Flow | -154,379 | -141,871 | -173,709 | -146,437 | -122,194 |